Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2 CAD -0.5% Market Closed
Market Cap: 129.3m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arch Biopartners Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Cash & Cash Equivalents
CA$44k
CAGR 3-Years
-11%
CAGR 5-Years
-45%
CAGR 10-Years
-13%
Abcellera Biologics Inc
NASDAQ:ABCL
Cash & Cash Equivalents
$133.3m
CAGR 3-Years
-39%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Cash & Cash Equivalents
CA$15.2k
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
-41%
Innovotech Inc
XTSX:IOT
Cash & Cash Equivalents
CA$120.5k
CAGR 3-Years
-41%
CAGR 5-Years
39%
CAGR 10-Years
6%

See Also

What is Arch Biopartners Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
44k CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Cash & Cash Equivalents amounts to 44k CAD.

What is Arch Biopartners Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-13%

Over the last year, the Cash & Cash Equivalents growth was -7%. The average annual Cash & Cash Equivalents growth rates for Arch Biopartners Inc have been -11% over the past three years , -45% over the past five years , and -13% over the past ten years .

Back to Top